CME vs. NDAQ

In the year-to-date period, CME achieves a 13.93% return, which is significantly higher than NDAQ's -3.00% return. Over the past 10 years, CME has underperformed NDAQ with an annualized return of 16.09%, while NDAQ has yielded a comparatively higher 18.60% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for CME Group Inc. (CME) and Nasdaq, Inc. (NDAQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CME Sharpe Ratio is 1.60, which is higher than the NDAQ Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of CME and NDAQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

CME's dividend yield for the trailing twelve months is around 3.99%, more than NDAQ's 1.28% yield.

The maximum CME drawdown since its inception was -77.50%, which is greater than NDAQ's maximum drawdown of -68.48%. Use the drawdown chart below to compare losses from any high point for CME and NDAQ. For additional features, visit the drawdowns tool.

The current volatility for CME Group Inc. (CME) is 7.31%, while Nasdaq, Inc. (NDAQ) has a volatility of 15.01%. This indicates that CME experiences smaller price fluctuations and is considered to be less risky than NDAQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between CME Group Inc. and Nasdaq, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.